Delivery Order SPE2DB22D2007-SPE2DB24FJ5VB
Award Date
9/5/24
Potential Completion Date
9/26/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,845.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is December 31, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product NUBEQA 300 MG TABLET 120S, with a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to supply a wide range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,518.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a ceiling value of $3,518.40 and a completion date of May 24, 2024, is for the provision of the pharmaceutical product NUBEQA 300 MG TABLET 120S. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of NUBEQA 300 MG Tablets. The $4,683.97 firm fixed price contract has a ceiling value and an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As a key supplier of medical commodities to the U.S. federal government, Amerisourcebergen leverages its extensive distribution network to provide a...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565519528 - NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ5DR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $4,683.97 firm fixed price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the drug NUBEQA 300 MG TABLET 120S and has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,518.40 firm fixed price contract is for the provision of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of February 27, 2024 and was awarded on February 5, 2024. Amerisourcebergen Drug Corp serves as a prime...